2019
DOI: 10.1038/s41598-019-51349-9
|View full text |Cite
|
Sign up to set email alerts
|

Regulatory Crosstalk of Doxorubicin, Estradiol and TNFα Combined Treatment in Breast Cancer-derived Cell Lines

Abstract: We present a new model of ESR1 network regulation based on analysis of Doxorubicin, Estradiol, and TNFα combination treatment in MCF-7. We used Doxorubicin as a therapeutic agent, TNFα as marker and mediator of an inflammatory microenvironment and 17β-Estradiol (E2) as an agonist of Estrogen Receptors, known predisposing factor for hormone-driven breast cancer, whose pharmacological inhibition reduces the risk of breast cancer recurrence. Based on the results of transcriptomics analysis, we found 71 differenti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 30 publications
0
2
0
Order By: Relevance
“…We used both a commonly used chemotherapeutic drug that activates the DNA damage response, and a selective MDM2 inhibitor that results in acute p53 activation without apparent genotoxic response ( Rizzotto et al., 2020 ; Tovar et al., 2006 ). Doses and treatment time points were selected based on previous characterization of both p53 activation pathway and cell outcome ( Lion et al., 2013 ; Nassiri et al., 2019 ). Furthermore, for both treatments, we have previously shown a global as well as a specific impact on translation ( Zaccara et al., 2014 ).…”
Section: Discussionmentioning
confidence: 99%
“…We used both a commonly used chemotherapeutic drug that activates the DNA damage response, and a selective MDM2 inhibitor that results in acute p53 activation without apparent genotoxic response ( Rizzotto et al., 2020 ; Tovar et al., 2006 ). Doses and treatment time points were selected based on previous characterization of both p53 activation pathway and cell outcome ( Lion et al., 2013 ; Nassiri et al., 2019 ). Furthermore, for both treatments, we have previously shown a global as well as a specific impact on translation ( Zaccara et al., 2014 ).…”
Section: Discussionmentioning
confidence: 99%
“…The fragments per kilobase million (FPKM) values of the TCGA cohort were then transformed into transcripts per million (TPM) values before further analysis. The GSE23610 (GSM578941, GSM578942, GSM578943, GSM578956, GSM578957, and GSM578958) [ 11 ], GSE39870 (GSM980568, GSM980569, GSM980570, GSM980571, GSM980572, and GSM980573) [ 59 ], GSE50650 (GSM1225765, GSM1225766, GSM1225767, GSM1225768, GSM1225769, GSM1225770, GSM1225771, GSM1225772, and GSM1225773) [ 60 ], and GSE68026 (GSM1661360, GSM1661361, GSM1661362, GSM1661363, GSM1661364, and GSM1661365) datasets were downloaded from the GEO ( https://www.ncbi.nlm.nih.gov/geo ) database.…”
Section: Methodsmentioning
confidence: 99%